Metraipolis › archive › dc_3de9fed05d0d

Safety and Efficacy of Concomitant Administration of Nanoliposomal Irinotecan + 5-Fluorouracil/Levo-Leucovorin for Pancreatic Cancer — Europe PMC PMID:41645046

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41645046
DOI
10.1002/cnr2.70485
License (as archived)
solo-consultazione
Archived
2026-11-06T08:34:19.037Z
SHA-256 of the archived text
e034ff4cb18325c27fc82a84dbbc2fd13a0f39f8cfbec34397a56d3daf976637
Stable URL of this page
https://metraipolis.com/documento/dc_3de9fed05d0d

How to cite

Safety and Efficacy of Concomitant Administration of Nanoliposomal Irinotecan + 5-Fluorouracil/Levo-Leucovorin for Pancreatic Cancer — Europe PMC PMID:41645046 — Europe PMC (en), https://europepmc.org/article/MED/41645046 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3de9fed05d0d (Metraipolis archive dc_3de9fed05d0d, sha256 e034ff4cb18325c27fc82a84dbbc2fd13a0f39f8cfbec34397a56d3daf976637)
BibTeX
@misc{dc3de9fed05d0d,
  title = {Safety and Efficacy of Concomitant Administration of Nanoliposomal Irinotecan + 5-Fluorouracil/Levo-Leucovorin for Pancreatic Cancer — Europe PMC PMID:41645046},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41645046},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3de9fed05d0d; sha256 e034ff4cb18325c27fc82a84dbbc2fd13a0f39f8cfbec34397a56d3daf976637},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41645046. Agents can read the archived copy with the MCP tool read_document.